University of Tennessee Cancer Institute — Bartlett, Tennessee

University of Tennessee Cancer Institute is a clinical research site located in Bartlett, Tennessee, United States 38133.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

University of Tennessee Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB.

Sponsors: NovaRx Corporation.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Cancer Institute?

University of Tennessee Cancer Institute has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Cancer Institute conducted?

University of Tennessee Cancer Institute has 1 clinical trials on record. Their work covers Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB.

Is University of Tennessee Cancer Institute accredited by Crixeo Health?

University of Tennessee Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Tennessee Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.